DEXCOM INC (DC4.DE) Stock Fundamental Analysis
FRA:DC4 - Deutsche Boerse Ag - US2521311074 - Common Stock - Currency: EUR
DC4 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. DC4 scores excellent on profitability, but there are some minor concerns on its financial health. DC4 is valued quite expensively, but it does show have an excellent growth rating. With these ratings, DC4 could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
DC4 had positive earnings in the past year.
In the past year DC4 had a positive cash flow from operations.
DC4 had positive earnings in each of the past 5 years.
DC4 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DC4 has a better Return On Assets (8.89%) than 85.45% of its industry peers.
DC4's Return On Equity of 27.40% is amongst the best of the industry. DC4 outperforms 92.73% of its industry peers.
DC4's Return On Invested Capital of 14.49% is amongst the best of the industry. DC4 outperforms 94.55% of its industry peers.
DC4 had an Average Return On Invested Capital over the past 3 years of 11.25%. This is above the industry average of 8.28%.
The 3 year average ROIC (11.25%) for DC4 is below the current ROIC(14.49%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.89% | ||
| ROE | 27.4% | ||
| ROIC | 14.49% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
DC4 has a Profit Margin of 14.29%. This is amongst the best in the industry. DC4 outperforms 85.45% of its industry peers.
DC4's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 16.20%, DC4 belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Operating Margin of DC4 has grown nicely.
DC4's Gross Margin of 61.78% is in line compared to the rest of the industry. DC4 outperforms 58.18% of its industry peers.
In the last couple of years the Gross Margin of DC4 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.2% | ||
| PM (TTM) | 14.29% | ||
| GM | 61.78% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DC4 is creating some value.
Compared to 1 year ago, DC4 has more shares outstanding
Compared to 5 years ago, DC4 has more shares outstanding
The debt/assets ratio for DC4 has been reduced compared to a year ago.
2.2 Solvency
DC4 has an Altman-Z score of 5.84. This indicates that DC4 is financially healthy and has little risk of bankruptcy at the moment.
DC4's Altman-Z score of 5.84 is amongst the best of the industry. DC4 outperforms 92.73% of its industry peers.
The Debt to FCF ratio of DC4 is 3.96, which is a good value as it means it would take DC4, 3.96 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.96, DC4 is doing good in the industry, outperforming 74.55% of the companies in the same industry.
A Debt/Equity ratio of 0.62 indicates that DC4 is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.62, DC4 is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 3.96 | ||
| Altman-Z | 5.84 |
ROIC/WACC1.74
WACC8.32%
2.3 Liquidity
DC4 has a Current Ratio of 1.47. This is a normal value and indicates that DC4 is financially healthy and should not expect problems in meeting its short term obligations.
DC4 has a Current ratio of 1.47. This is comparable to the rest of the industry: DC4 outperforms 49.09% of its industry peers.
A Quick Ratio of 1.28 indicates that DC4 should not have too much problems paying its short term obligations.
DC4's Quick ratio of 1.28 is fine compared to the rest of the industry. DC4 outperforms 70.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.47 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.27% over the past year.
Measured over the past years, DC4 shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
DC4 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.34%.
The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.27%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%-10%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%7.64%
3.2 Future
DC4 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.71% yearly.
DC4 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.01% yearly.
EPS Next Y24.7%
EPS Next 2Y23.7%
EPS Next 3Y23.36%
EPS Next 5Y21.71%
Revenue Next Year14.47%
Revenue Next 2Y15.03%
Revenue Next 3Y15.08%
Revenue Next 5Y14.01%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 48.50, DC4 can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of DC4 is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 29.35. DC4 is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 38.90 indicates a quite expensive valuation of DC4.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DC4 is on the same level as its industry peers.
DC4's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.5 | ||
| Fwd PE | 38.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DC4 is on the same level as its industry peers.
65.45% of the companies in the same industry are more expensive than DC4, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.59 | ||
| EV/EBITDA | 33.54 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DC4 does not grow enough to justify the current Price/Earnings ratio.
DC4 has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DC4's earnings are expected to grow with 23.36% in the coming years.
PEG (NY)1.96
PEG (5Y)1.66
EPS Next 2Y23.7%
EPS Next 3Y23.36%
5. Dividend
5.1 Amount
No dividends for DC4!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:DC4 (3/7/2025, 7:00:00 PM)
73.72
-1.54 (-2.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners96.25%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap28.81B
Analysts86.25
Price Target99.34 (34.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.07%
Min EPS beat(2)-11.66%
Max EPS beat(2)1.51%
EPS beat(4)3
Avg EPS beat(4)3.82%
Min EPS beat(4)-11.66%
Max EPS beat(4)16.17%
EPS beat(8)7
Avg EPS beat(8)16.74%
EPS beat(12)9
Avg EPS beat(12)9.83%
EPS beat(16)12
Avg EPS beat(16)13.09%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-2.13%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)-0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)7
Avg Revenue beat(16)0.05%
PT rev (1m)4.07%
PT rev (3m)6.82%
EPS NQ rev (1m)-13.37%
EPS NQ rev (3m)-17.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.5 | ||
| Fwd PE | 38.9 | ||
| P/S | 7.76 | ||
| P/FCF | 49.59 | ||
| P/OCF | 31.61 | ||
| P/B | 14.88 | ||
| P/tB | 15.82 | ||
| EV/EBITDA | 33.54 |
EPS(TTM)1.52
EY2.06%
EPS(NY)1.9
Fwd EY2.57%
FCF(TTM)1.49
FCFY2.02%
OCF(TTM)2.33
OCFY3.16%
SpS9.51
BVpS4.96
TBVpS4.66
PEG (NY)1.96
PEG (5Y)1.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.89% | ||
| ROE | 27.4% | ||
| ROCE | 18.4% | ||
| ROIC | 14.49% | ||
| ROICexc | 52.88% | ||
| ROICexgc | 60.76% | ||
| OM | 16.2% | ||
| PM (TTM) | 14.29% | ||
| GM | 61.78% | ||
| FCFM | 15.64% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexcg growth 3Y55.18%
ROICexcg growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score7
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 3.96 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 164.81% | ||
| Cap/Sales | 8.9% | ||
| Interest Coverage | 57.32 | ||
| Cash Conversion | 113.58% | ||
| Profit Quality | 109.46% | ||
| Current Ratio | 1.47 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z | 5.84 |
F-Score7
WACC8.32%
ROIC/WACC1.74
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)9.27%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%-10%
EPS Next Y24.7%
EPS Next 2Y23.7%
EPS Next 3Y23.36%
EPS Next 5Y21.71%
Revenue 1Y (TTM)11.34%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%7.64%
Revenue Next Year14.47%
Revenue Next 2Y15.03%
Revenue Next 3Y15.08%
Revenue Next 5Y14.01%
EBIT growth 1Y6.38%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year79.19%
EBIT Next 3Y38.49%
EBIT Next 5Y28.14%
FCF growth 1Y23.21%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y32.2%
OCF growth 3Y30.77%
OCF growth 5Y25.76%